To the Editor: Methicillin-resistant Staphylococcus aureus (MRSA) are a group of gram-positive bacteria that cause a wide range of diseases in children. [1] Surveillance of MRSA is particularly important since certain clones have spread over wide geographical regions. The MRSA clones that have spread in North China over the past decade include ST59-SCCmecIVa-t437, ST59-SCCmecV-t437, and ST239-SCCmecIII-t030.
MRSA toxins that can damage the host cell membrane include a, b, d, and g hemolysin. The hemolytic activities of these toxins were described in 1944 by Christie, Atkins, and Munch-Petersen (which was called the CAMP reaction). [2] The hemolytic activities of MRSA isolated from Chinese children have not yet been determined. The aim of this study was to provide novel insights into hemolytic activities of these isolates.
The key laboratory routinely received MRSA-positive samples that were isolated from patients in the bacteriology room (18 years old) of Beijing Children's Hospital (BCH) over three different periods (2005-2011, 2012-2013, 2016) . Invasive MRSA isolates were included as previously described. [3] The CAMP test was performed for hemolysis. Briefly, 5% sheep blood agar (SBA) plates were prepared using defibrinated sheep blood (5% in tryptone soy broth [TSB; Becton, Dickinson and Company, Franklin Lakes, NJ, USA], 25 mL per plate). A S. aureus strain of RN4220 that produced b-hemolysis was streaked down at the centre of an SBA plate. Test strains were streaked perpendicular to the center streak, but without touching it. The plates were incubated at 37°C for 24 h before analysis.
DNA isolation and polymerase chain reaction amplification were used for multi-locus sequence typing (MLST), SCCmec typing, accessory gene regulator (agr) typing, spa typing, the intact hlb gene, the int gene, the hla, and hld gene as previously described. The SCCmecIII type was not detected in 2016. Four agr types were detected during the study; the main type was agrI, with incidence increasing from 72.9% in 2005 to 2011 to 88.9% in 2012 to 2013, and increasing further to 92% in 2016 (P < 0.01). Our results revealed that isolates sharing the genetic characteristics of ST59-SCCmecV-spa-t437-agrI increased from 24.3% (17/70) in 2005 to 2011 and 31.1% (28/90) in 2012 to 2013 to 59.6% (59/99) in 2016 (P < 0.001). On the contrary, the ST239-SCCmecIII-t030-agrI clone disappeared in 2016.
S. aureus produces at least four hemolytic activities, a, b, d, and g. a-Hemolysis generates a wide zone of complete hemolysis with blurred edges on sheep blood agar (SBA). b-Hemolysis produces a wide zone of incomplete hemolysis with sharp edges. d-Hemolysis is a narrow zone of incomplete hemolysis with blurred edges. g-Hemolysis cannot be seen on SBA, as it is inhibited by agar.
b-Hemolysis partially inhibits a-hemolysis, which leads to a more turbid zone than that produced by a-hemolysis alone [ Figure 1E ]. d-Hemolysis is strongly synergistic with b-hemolysis, producing a turbid zone that is broader than that produced by d-hemolysis [ Figure 1D ]. These hemolytic patterns are illustrated in Figure 1 .
Four hemolytic patterns were observed in our study: a and d; b and d; b and d alone. 143 ST59 isolates, 118 t437 isolates, 134 SCCmecIV and 151 agrI isolates exhibited Chinese Medical Journal 2020;133 (1) www.cmj.org b-and d-hemolysis, which accounted for 93.5%, 77.1%, 87.6%, and 98.7% of all b-and d-hemolytic isolates, respectively. Among isolates that showed band d-hemolysis, 100 (65.4%) were ST59-SCCmecIV-t437-agrI clones.
All isolates carried the hla and hld genes, and the intact hlb gene was found in 97.4% (149/153) of isolates that exhibited b-hemolysis. The int gene was detected in 94.1% (80/85) of the isolates that showed a-hemolysis.
Among 259 children, 40 (15.4%) were classified as cases of invasive S. aureus infection. These patients came from all over the country, with cases coming from the provinces of Anhui, Hubei, Hebei, Shandong and Shanxi as well as from Beijing city. There was no significant correlation between hemolysis type of MRSA isolates and the periods of study, age, sex of infected children, admission to pediatric intensive care unit (PICU), and diagnosis (P > 0.05).
Since the first detection of MRSA, different STs have emerged as predominant clones in different geographical regions. ST239 has become the predominant hospitalassociated (HA-) MRSA clone, while ST59-IV and ST30-IV have become the predominant community-associated (CA-) MRSA clones in Asia. In our study, ST59-t437-IV was the dominant CA-and HA-MRSA clone in the hospital instead of ST239. However, the factors contributing to its epidemic are still unclear.
MRSA virulence factors include exotoxins that can damage the host plasma membrane such as pore-forming toxins (a-, d-, and g-hemolysin) and a neutral sphingomyelinase (b-hemolysin). Among these exotoxins, a-hemolysin, in particular, has been shown to have critical role in MRSA associated with severe disease. [4] As shown in this study, the dominant MRSA ST59 clone did not produce a-hemolysis, thus suggesting a dysfunction of a-hemolysin. Meanwhile, our data showed that the ST239 clone, which had decreasing incidence in the study, produced a-hemolysis. The shift in the STs coincided with differences in hemolytic patterns.
In S. aureus, agr is a two-component regulatory system that separately controls the production of a-and d-hemolysin. [5] Previous studies have shown that the b-hemolysin gene is non-functional in most clinical S. aureus strains due to the insertion of the bacteriophage phi 13, while most bovine S. aureus isolates express b-hemolysin. In contrast, in this study, most isolates (97.4%) with the b and d phenotype carried the intact hlb gene, indicating that the bacteriophage phi 13 was absent in these strains.
There was no correlation between the hemolytic phenotype of invasive isolates and the clinical characteristics of the isolates, which may also be related to the small sample size and result bias.
In conclusion, the predominant ST59 clone produced b-hemolysis instead of a-hemolysis. The a-hemolysis defective ST59 infections took place both in the community and at the hospital.
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